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This paper describes the historyofthe epidemiologic research on lung cancer prior to 1970 and
its effect on chronic disease epidemiology. In the 1930s, epidemiology was largely concerned with
acute infectious diseases. As the evidence grew that the incidence of lung cancer was increasing
among men, however, epidemiologists undertook research into theetiologyofthedisease. In 1950,
Doll and Hill, in England, and Wynder and Graham, in the United States, published substantial
case-control studies that implicated the use of tobacco as a major risk factor for the disease. A
controversy developed over thecredibility ofthis finding and was increased in 1954 when a cohort
study by Doll and Hill and another by Hammond and Horn each gave estimates that the risk of
lung cancer was greatly increased among smokers relative to the risk among comparable
non-smokers. An account is given of the disputes surrounding these and related studies. The
controversy had a stimulating effect in fostering the developing discipline ofchronic disease and
epidemiology.
Wade Hampton Frost, the first profession of epidemiology in the United States,
described epidemiology in 1926 as concerned largely with the mass phenomena of
infectious disease [1]. He did point out, however, that the limits of the discipline had
become somewhat vague. It was customary to include in epidemiology the study of
infections which were not characterized by distinctive epidemics, since these diseases
had much in common with traditional epidemic diseases. He did not specifically
include the effects of famine, which, on account of its role in dramatic depopulation,
had often been linked with pestilence, but he did include a food deficiency disease,
scurvy, and he also included goiter, which, like the others, could be profitably
considered, in relation to the population at risk, a characteristic epidemiologic concept.
In the nineteen thirties, epidemiology was still concerned almost entirely with acute
infectious diseases. Chronic diseases were becoming more important in the health field
as a whole, however, partly in a relative sense becauseofthecontrol ofmany infections,
but also, to some extent, because ofan increase in the incidence rate ofcertain chronic
diseases. J.N. Morris, writing about British mortality data on middle-aged men, noted
that as early as the 1920s death rates from coronary heart disease and lung cancer in
men had been increasing. In a later part of his book he referred to these diseases as
causing modern epidemics [2]. They showed a sustained, rather than an episodic,
increase, less dramatic than a classic epidemic, but, like the latter, they invited
attention by reason ofthe number ofpeople affected.
A few small-scale epidemiologic investigations ofthe etiology ofchronic disease had
already been undertaken by the thirties. The rising interest in the field is illustrated by
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the sustained cooperative efforts which were mounted at that period to gather data on
the natural history of cancer. In 1935, the Connecticut State Legislature authorized a
population-based cancer registry [3]. Two years later the National Cancer Institute
was founded in the United States, and the first of three national cancer surveys, the
Ten-City Survey, was organized [4]. In Denmark, a cancer registry covering the whole
population was set up in 1942 [5]. These major undertakings were not restricted to
research objectives, but the data obtained have served this purpose well.
What was still lacking in epidemiology at this time, however, was the successful
completion of a major investigation of the etiology of a chronic disease. In the late
forties, two large programs of epidemiologic research in chronic disease developed in
response to the challenge of rising morbidity and mortality rates: research on smoking
and lung cancer, carried out through several individual projects, and the Framingham
study of cardiovascular disease, another comprehenisve program of research. The
objective ofthe present article is to describe the history ofthe research on lung cancer,
briefly prior to 1950, and in greater detail for the more eventful period of 1950 to 1970,
and to illustrate the stimulating effect of this research on the development of chronic
disease epidemiology.
WAS LUNG CANCER INCREASING IN FREQUENCY?
CONTROVERSY PRIOR TO 1950s
In the early part of this century, primary carcinoma of the lung was, according to
Adler, "among the rarest forms ofdisease" [6]; a similar statement had been made by
Bland-Sutton in 1903 [7]. By the 1930s, some evidence had been obtained that the
incidence of lung cancer among males was increasing. The evidence came from three
sources: official mortality statistics, pathologists' reports of autopsy findings, and the
observations of physicians who specialized in the treatment of lung disease. The view
that the disease was increasing provided a stimulus to search for a plausible cause,
which, ifthe increase were as rapid and as widespread as it seemed, might well prove to
be a changing environmental factor. Several such factors were suggested: one was the
use oftobacco, and others included exposure to pollutants such as automobile exhaust,
industrial pollution, smoke from domestic fires, and tars that were used in road
construction. Non-environmental factors included late sequelae of influenza or tuber-
culosis.
Speculation about these factors continued, but there was also much criticism of the
view that the reported increase in lung cancer was credible. These criticisms led to
debate throughout the forties and early fifties. An editorial in the British Medical
Journal in 1942 stated "It is doubtful whether the higher incidence of cancer of the
lung observed in recent years is real oronly apparent" [8]. Factors which were listed as
likely to be responsible for an artificial increase were betterdiagnosis ofthe disease and
increased longevity ofthe population.
The Medical Research Council of Great Britain in its report covering the years
1948-50 drew attention to the very great increase in the death rate from lung cancer
in the previous 25 years, but conceded that "the increase may, of course, be only
apparent" [9]. Its hedged conclusion was that it was reasonable to assume that the
increase was partly real.
An indication ofa developing consensus may be seen around 1950: Steiner, in 1950,
reversed the opinion he previously held, that the reported increase was an artifact [10],
and Clemmeson did likewise in 1954 [ 1], in the light ofexperience obtained after he
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and Buck had reached a contrary conclusion earlier [12]. The in-house comments of
the British Medical Journal also showed a change of emphasis from the editorial of
1942. A writer of the answers-to-correspondents column of 1948 stated without
qualification that cancer of the lung had increased in frequency [13], and an editorial
writer in 1950, impressed by substantial increases in proportionate mortality, noted
that in Britain, in 1920, 1.5 percent of cancer deaths in men were due to cancer of the
lung, and that this proportion increased to 19.7 percent in 1947 [14]. The writer added
that similar changes had occurred in the United States, Australia, Switzerland, and
Denmark.
In 1952, Lancet reported in an account of death rates, "Few trends are more
dramatic than the rise during the last 30 years in the notified death rate from cancer of
the lung. There is little doubt that the increase is both real and numerically important"
[15].
The incidence rate oflung cancer as recorded by population-based cancer registries
was greater in the forties than in the thirties and greater in thefifties than in theforties.
It was this increase that made the phenomenon obvious to most observers. Clemmeson,
director of the Danish Cancer Registry, wrote in 1954 that the rise was doubtful up
until 1930, but "the disease is now increasing on a pandemic scale" [16]. The rapidity
ofthe increase is illustrated by the following age-adjusted incidence rates per thousand
males per year for Connecticut [17]:
Period 1935-39 1940-44 1945-49 1950-54
Rate 9.7 13.0 20.6 31.1
The successive five-year percentage increases were 34 percent, 58 percent, and 51
percent. Thechanges recorded in Connecticut and elsewhere were too substantial to be
reasonably accounted for by underdiagnosis in the past. Doll has pointed out that ifthe
lung cancer death rates of the early fifties in Britain had applied at the turn of the
century, than 95 percent of fatal cases at that earlier time must have been wrongly
reported on the death certificate [18].
During the late forties and the fifties, improved methods of diagnosis had become
generally established. Physicians were assisted by the greater use of bronchoscopy
and by the use of antibiotics to uncover an underlying malignancy in persons with
pneumonia, and the population registries benefited from the higher quality of the data
they received. This change is shown by data from the Connecticut Cancer Registry on
the incidence of cancer of the trachea, bronchus, and lung over the period 1935-1954
[19]. The percentage of newly diagnosed males on whom the diagnosis had been
confirmed by histologic examination increased in this period from 44.8 to 68.4. In
addition, the percentage of cases that were registered on the basis of death certificate
only, that is, registered in the absence of clinical notes from a diagnostician, declined
from 32.2 to 16.6. These latter changes are affected by changes in survivorship, but
they also reflect the improvement in the quality ofthe data that were registered.
The suggestion made by Burch in 1976 that there was underdiagnosis in the early
years, followed byoverdiagnosis as awareness ofthedisease was enhanced [20], though
probably correct in qualitative terms, is implausible as a full explanation of the
reported increase. By 1976, at the Connecticut Cancer Registry, only 1 percent of the
cases oflung cancer were reported through death certificate alone, and only 12 percent
lacked histological confirmation, but at this time the incidence rate oflung cancer was
still increasing [21]. These facts undercut the claim that the reported increase in lung
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cancer at this period was based on false-positive diagnoses. In 1954, a group of
cigarette manufacturers in the United States made a statement acknowledging "the
increased incidence ofcancer of the lung in recent years," but denying that there was
any proofthat smoking was responsible [22].
There was a good reason for the early uncertainty about whether lung cancer had
been increasing, since the opposing views were initially based to a large extent on
mortality data, which had been obtained by different methods of study. On the one
hand, pathologists were conscious of the detailed work necessary to establish a
probable cause of death, and they distrusted cause-of-death statistics based on death
certificates; Willis argued that only "fully proved necropsy records" were of value in
studying the apparent secular increase in lung cancer [23]. On the other hand, students
of population were aware of the selective factors that influence the sample on which
autopsy data are based, and they emphasized that such samples, lacking a well-defined
population at risk, do not give a reliable guide to population trends in mortality.
Controversy about issues in science tends to be spirited when the participants come
from different disciplines, each with its own canons ofevidence [24].
CASE-CONTROL STUDIES: FINDINGS AND CRITICISM
It is easier to accept an empirical finding about a rising incidence ofcancer ifthere is
a reasonableexplanation ofwhy an increase might haveoccurred. In 1954, Clemmeson
flatly asserted that it was due to the widespread addiction to smoking [25]. It is well
known that the proportion ofsmokers, particularly cigarette smokers, in the population
of Western countries increased substantially during the first half of this century.
Initially "smokers" were rarely cigarette smokers, and Kenneth Grahame, in The
Wind in the Willows, refers to the use of cigarettes when "one is not smoking" [26].
The Department of Agriculture has made estimates of the average annual consump-
tion of tobacco products in the United States among persons aged 15 years and over,
from 1900 to 1960. During this period the number ofcigarettes marketed, per person,
increased by a factor ofabout 80, from 50 to 3,900; the sale ofpipe tobacco decreased
from 1.6 to .6 pounds, and the number ofcigars fell from 110 to 60, per person [27].
Doll has noted that it had been known long before 1950 that smoking could cause
disease, but it was "not until 1950 that a large amount of data was obtained in a
sufficiently representative and responsible way to lead more than a handful ofpeople to
believe that smoking might actually be responsible for causing a material amount of
disease" [28]. The two case-control studies in 1950 that were not only large but also
well conducted were by Wynder and Graham in the United States [29] and by Doll and
Hill in England [30,31]. The former was based on 605 cases and the latter was
enlarged in 1952 to include 1,465. At least seven smaller studies, in which an
association between smoking and lung cancer was found, were carried out prior to, or
during, 1950 [32], the earliest being the paper ofMuller on 86 cases and 86 controls in
1939 [33]. On the basis ofclinical impressions, Ochsner and DeBakey as early as 1941
expressed "a definite conviction that the increase of pulmonary carcinoma is due
largely to the increase in smoking, particularly cigarette smoking" [34].
Case-control methods were not new to epidemiology in 1950. One of the earliest
examples ofsuch investigation, indeed, was a matched study by Lombard and Doering
in 1928 [35], implicating pipe-smoking as a risk factor for oral cancer. The paper by
Doll and Hill in 1950, however, set higher standards than were previously attained in
case-control studies by taking into account, in the design or analysis, a range of
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potentially relevant factors: the age, sex, urban or rural residence, and social class of
the subject; occupational history; exposure to air pollutants; forms ofdomestic heating;
the place of interview; interviewer bias; diagnostic bias; and the history of smoking,
including, for those who had smoked, the age of starting and stopping, the amount
smoked before the onset of illness, the main changes in smoking history, the maximum
amount smoked, the practice in regard to inhaling, and the use of cigarettes or pipe.
They considered various possible explanations of their findings, searching for possible
causes of confounding. The British Medical Journal wrote a favorable review of the
paper, stating that it was meticulous and carried serious implications [36]. The paper
has been well described as the prototype of the case-control study [37].
There were many who cast doubt on the evidence that had been produced against
tobacco. One correspondent wrote to Lancet in 1951: "The evidence is purely circum-
stantial; it is obtained from statistical evaluation of clinical material" [38]. Another
wrote to the British Medical Journal in 1952, "The only known carcinogen in
cigarettes is arsenic. Some cause other than, or additional to, the increase in cigarette
consumption must be sought to explain the increase in bronchogenic cancer" [39]. This
important criticism was echoed by a correspondent to the British Medical Journal in
1953 who wrote: "no carcinogen has been found in tobacco smoke, although its
presence and ultimate recognition are implied" [40]. Other correspondents to the
British Medical Journal in 1953 raised objections to incriminating tobacco: "the fact
that non-smokers contract the disease proves that smoking can at most be an aggravat-
ing factor . . not the basic cause ofbronchogenic carcinoma" [41] and "there has been
no increase in the incidence of cancer of the mouth, tongue or pharynx" [42].
Other critics conceded that there was an association between smoking and lung
cancer but did not regard the connection as causal. In 1953, the Minister of Health
stated in the British Parliament: "The Standing Advisory Committee on Cancer and
Radiology and the Medical Research Council both advised me that the relationship
[between smoking and lung cancer] is not necessarily causal" [43] and in the same
year a paper on smoking and lung cancer included the assessment: "There is an
association but the question of whether smoking causes cancer is still open" [44].
Many essentially repetitive case-control studies of smoking and lung cancer were to
follow. The large number was due to the disturbing finding that a pleasant and popular
habit was, in the long term, potentially lethal. Conviction that this was so did not come
easily. There was still the possibility, even, many thought, the near certainty, of the
eventual emergence of credible scientific opposition which could, indeed, be expected
since the finding at issue was somewhat inconclusive technically and the risk factor had
been present for many years without exciting suspicion. In this case also, the product
under discussion, tobacco, was sufficiently important economically to ensure its
adequate defense. In 1954, the American Tobacco Industry issued a statement
expressing confidence that this defense would prevail: "[It] accepts an interest in
people's health as a basic responsibility paramount to every other consideration in our
business" but does not "believe that tobacco products are injurious to health" [45].
One important criticism of the finding of an association between smoking and lung
cancer centered on the use of the case-control method. It was expressed strongly in
1954 by Hammond [46], who was convinced that the increase in the incidence of lung
cancer was real, and the resulting problem a serious one, and who was at that very time
conducting, with Horn, a study which was subsequently to play an important part in
concluding that the smoking of cigarettes was the major etiologic factor. The only
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virtue he found in the case-control method was that under favorable conditions it was
quick and inexpensive. He referred to the difficulty ofobtaining appropriate controls,
and he considered that an investigator who believed that tobacco caused lung cancer
could influence a case's response to thequestion on smoking history. He also referred to
what became known as Berkson's bias, which is based on theunrepresentative natureof
prevalent hospital populations when used to reflect relationships that apply in the
community. Because of the defects of the case-control method, some statisticians,
Hammond reported, "believe that it leads to erroneous conclusions more often than to
correct." Thirty years later Doll noted that bias "in theopinion ofmany at the timewas
inherent in the case-control method" [47].
COHORT STUDIES
This methodological criticism was met in part by the planning ofstudies in which the
outcome was unknown at the time of enrollment of subjects, since the contrasting
groups ofsubjects were smokers and non-smokers rather than cases oflung cancer and
controls. This design was originally described as prospective and has come to be known
as the prospective cohort design. The term "cohort" is used in demography to denote a
group ofpeople who have all experienced some event within a defined calendar period,
for example, a birth cohort or a marriage cohort. Thedefining event in the cohortstudy
of lung cancer is the presence or absence of exposure, in this case the exposure due to
smoking cigarettes, and since the onset of exposure may vary widely in calendar time
even within one age group, the meaning ofthe word "cohort" is being extended in this
epidemiologic usage; enrollment in a study is not an event in thedemographic sense.
The use ofthe cohortdesign tostudy an etiologicproblem in non-infectiousdisease is
an advance that resulted from the research on smoking. Cohort studies ofother types
had long been used. The cohort life table, for example, in which the proportion
surviving from a birth cohort is traced year by year to the point ofextinction, was used
by Deparcieux as early as 1746 [48]. In the nineteen thirties, Wade Hampton Frost
took the step ofadapting life table methods to study the epidemiology ofan infectious
disease, tuberculosis, as revealed by the follow-up cases [49], and his work on this
disease was continued by several students.
It is therefore understandable, in the light of this experience in handling data on
cohorts, that Doll should write in 1964: "theprospective methodofinquiry is in concept
extremely simple" [50]. The practical difficulties in applying the method to epidemio-
logic problems of the type raised by cigarette smoking were nevertheless considerable.
Cornfield, who was experienced both in research on smoking and in the design of
epidemiologic studies, had written in 1951: "An investigation that involves selecting
representative groups of those having, and [others] not having, a characteristic is
expensive and time consuming ... and is rarely if ever used" [51]. In the early fifties,
these problems were overcome by Doll and Hill [52,53] and by Hammond and Horn
[54,55,56] in their research on smoking, the former having a slight priority in date of
publication. At about the same time, a related type of cohort study was described by
Case and colleagues [57], one in which the cohort was identified at some point in the
past, then followed to the present time by means of available records, and finally
followed prospectively, during a period in which most of the outcome events occurred,
to the end of the study. This procedure is the historical cohort type of study. The
research by Case and colleagues on the causation of cancer of the bladder by dyestuff
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intermediates was published in 1954, the same year as the Doll and Hill cohort study,
and the two have been coupled as a landmark in the historical development of cancer
epidemiology, and thus in the development ofchronic disease epidemiology in general
[58]. What is novel about their use of this method is its application to the study ofthe
etiology of a non-infectious disease. Following these examples, similar cohort studies
on a smaller scale have become routine [59]. When the acute stage of an infectious
disease blends with chronic sequelae as in tuberculosis, it is clear that follow-up ofthe
cohort affected is needed both for purposes of treatment and for progress in knowledge
of the disease. When there is no such natural link between risk factor and resulting
pathology, there is less encouragement to undertake a long and potentially expensive
cohort study. The findings from the case-control studies of smoking, however, though
challenging, had not convinced some whose judgment had to be respected, and the
value ofan independent method ofstudying the problem was obvious.
The first two cohort studies of the effects of smoking began soon after the case-
control investigations ended. Doll and Hill sent out questionnaires to British physicians
in October 1951 and obtained 40,000 usable responses. In early 1952, Hammond and
Horn, ofthe American CancerSociety, began their questioning of 188,000 white males
all in the age group 50 to 69. Within the same decade, four other large cohorts were
enrolled in similar studies [60]. What is of interest in the outcome is the general
concordance in findings between the cohort studies and between the cohort and the
earlier case-control studies. It is true that in the British research the lung cancer death
rate was substantially higher in the case-control than in the cohort study, but the
former estimate involved some data that were obtained outside the study and was
necessarily tentative.
The cohort studies verified the association between smoking and lung cancer and
also found that the lung cancer death rate was substantially higher in cigarette smokers
than in smokers who used pipes or cigars; that the strength of the association between
smoking and lung cancer increased with the amount of smoking; that the association
differed according to the histological type of tumor; and that those who renounced
smoking had a lower death rate than otherwise comparable subjects who continued to
smoke. An important additional finding of the type possible in cohort studies, which
can monitor the outcome in several diseases, was that cigarette smoking is a risk factor
for coronary heart disease. This finding was initially missed by the Framingham study
ofcardiovascular disease which, in 1950, had become oriented toward the study ofrisk
factors. A 1957 paper from Framingham noted that Hammond and Horn, and Doll
and Hill, had found an association between smoking and cardiovascular disease, but
added that in the Framingham study "smoking habits were not notably associated with
the development of new arteriosclerotic heart disease" [61]. New disease included
angina as well as the fatal forms ofdisease studied by Hammond and Horn. A further
analysis ofthe Framingham data, in which angina pectoris was treated separately, was
made in 1959, and a weak but positive association with smoking was observed [62]. In
1962, data from Framingham were merged with those from a similar Albany study,
and heavy smokers were estimated to have three times the risk of cardiovascular
disease experienced by non-smokers [63]. It is likely that the person-years ofexposure
in the Framingham study were too small at the time of the early reports to provide
convincing evidence ofthe effect ofsmoking on cardiovascular disease. Hammond and
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Horn, in particular, must be given credit for producing data which convincingly
established cigarette smoking as a risk factor for coronary heart disease.
FURTHER DISCUSSION OF EVIDENCE: RENEWAL OF CONTROVERSY
A third substantial cohort study of smoking, based on United States veterans, was
published in 1959 [64]. The fifties and early sixties may be considered to be the period
in which the epidemiologic data in favor ofthe etiologic role oftobacco in lung cancer
were marshalled, and opinion against smoking began to crystallize. In 1957, the
Medical Research Council in Britain issued a strong statement in which it claimed that
the occurrence ofmost ofthe lung cancer cases was associated with the use oftobacco,
particularly in the form ofcigarettes, and the most reasonable interpretation was that
tobacco was the direct cause ofthe cancer [65].
The Surgeon General ofthe United States tooka similarposition: "Theweightofthe
evidence is increasingly pointed in one direction: that excess smoking is one of the
causative factors in lung cancer" [66]. The definitive results ofthe Doll and Hill cohort
study and the Hammond-Horn study were available at that time. These papers and the
discussion they stimulated helped to set off a new period of controversy which was to
last for at least another decade. Following the publication of the statement by the
Medical Research Council in Great Britain in 1957, the Minister of Health, Dr. Hill,
was asked the following Parliamentary Question: "Are there not strong grounds for
thinking that the Medical Research Council has stuck out its neck much too far?" Dr.
Hill replied: "The facts are clearly known. The case has been fully established" [67].
For him, the evidence against cigarettes in 1957 was beyond the reach of successful
contradiction.
In this same year, however, Compton Mackenzie published his book, Sublime
Tobacco [68]. He stated that he wrote it "as a token of gratitude for the immense
benefit I have received from tobacco, and in complete certainty that I have not derived
from it the slightest harm." A reviewer for Lancet praised the graceful and elegant
style, but also claimed that the book was dangerous, perhaps immoral [69].
In 1956, the British Medical Journal published the answers given by Doll and Hill
to 31 questions it had submitted to them about smoking and lung cancer [70]. It is an
indication ofthejournal's assessment ofreader interest that so many facets were found
on which medical practitioners might require information or reassurance. Five years
later, the New England Journal ofMedicine carried out a similar policy, in its own
way, by publishing details of a debate on the same subject between E.L. Wynder [711
and C.C. Little [72].
In 1959, the Surgeon General of the United States, Dr. Leroy E. Burney, issued a
statement which reviewed the available data and concluded: "The weight of evidence
at present implicates smoking as the principal etiological factor in the increased
incidence of lung cancer" [73]. What the Surgeon General had referred to two years
previously as "one of the causative factors" had become "the principal etiological
factor." The editor of the Journal ofthe American Medical Association, Dr. Talbot,
published the statement and added in an editorial "a number of authorities ... do not
agree with his conclusion" [74]. Dr. Talbot argued that there was insufficient evidence
to resolve the issue. His advice was that physicians should watch the situation closely,
keeping courant of the facts, and advise patients on the basis ofappraisal ofthe facts.
This recommendation drew a response from the editor of the New EnglandJournal of
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Medicine, who saw the cautious phrasing of Dr. Talbot's statement as encouraging
indecisiveness which could no longer bejustified; this encouragement, he wrote, might
have been unintentional, but he made his own position clear by strongly endorsing Dr.
Burney's views [75]. More detailed and stronger statements were to follow from the
Royal College ofPhysicians of London in 1962 [76] and from the Advisory Committee
to the United States Surgeon General in 1964 [77]. In response to the Surgeon
General's Report, the American Medical Association agreed that cigarette smoking
was a serious health hazard [78].
CRITICISMS BY JOSEPH BERKSON
Since the epidemiologic evidence against smoking, like many of the findings of
chronic disease epidemiology, draws on statistical analyses, great interest was roused
by the fact that two well-known statisticians, Joseph Berkson and R.A. Fisher, did not
accept the claim that smoking caused lung cancer.
Berkson was impressed by the large number of diseases that Hammond and Horn
showed to differsignificantly in frequency between smokers and non-smokers. The list,
expressed in the rubrics used by the International Classification of Causes of Death,
included not only cancer of the lung, although the risk of smokers relative to
non-smokers for this condition was extraordinarily high, but also such disease out-
comes as cancer of the bladder, coronary heart disease, cardiovascular disease, aortic
aneurysm, pneumonia and influenza, and gastric ulcer and duodenal ulcer. Berkson
wrote: "We have here agreat deal more than was bargained for, and most of it without
relation to what it was intended to explain, the observed rise in death rate from cancer
of the lung" [79]. Berkson's argument had been commonly used in infectious disease
epidemiology and had been recommended, with reservation, when one wished to infer
causality instudying theetiology ofchronic diseases. Specificity ofaction is a principle
which workswell in studies made at the molecular level. Ifthe unit ofstudy is the whole
organism, however, the principle ofspecificity has limited usefulness, although it may
sometimes warn of false-positive associations. The absorption of even a single sub-
stance, let alone thecomplex smoke from tobacco, may affect many organs or systems.
Berkson advanced anothergeneral argument which was repeated in various ways in
the debate about cigarettes. "The definitive investigations," he wrote, "must come
from the biologic sciences, pathology, pharmacology, chemistry and so forth ... we
will notreally know whethersmoking causes cancer, till we know at least something in
a precise way about how it causes cancer" [80].
Many critics either agreed with the phrase "not really know" or, at any rate,
considered that evidence at a more analytic biological level was desirable. They made
Berkson's argument more pointed by asking once again for evidence of the precise
substance that constituted the active principle of tobacco, and demanding the experi-
mental production ofcancer by this substance.
In the fifties, even before Berkson had stated his view, a vigorous effort was made to
isolate chemical carcinogens from tobacco. The model for this was the isolation from
coal tar in 1932 of a very active carcinogen, 3,4-benzypyrene [81], which was
presumably the main agent responsible for chimney sweepers' cancer. There were
numerous examples from biomedical research ofthe success which could ensue when a
crude biological product was fractionated to isolate the active component. Many years
previously, John Shaw Billings had drawn attention totheerror ofthose who had failed
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to follow this principle in the investigation of "milk sickness." He noted that he had
read 110 articles on the subject, and he then complained: "It has been said to be caused
by certain plants, yet no scientific experiments have been made on the effects of these
plants. No attempt has been made to produce the disease ... by the use of suspected
plants, or better, by the use ofan extract containing the active principles" [82].
In the case oftobacco the efforts were made, but the direct results from this strategy
were minimal. In 1958, by which time there was substantial epidemiologic evidence on
smoking as a risk factor for lung cancer, the British Medical Journal commented as
follows on this evidence: "The fact that experimental work has not provided complete
and irrefutable proof has tended to hinder its wholehearted acceptance" [83]. A
representative of the tobacco industry described this objection more forcefully, by
stating that the search for chemical carcinogens in tobacco "has now been continued so
long in the hands ofso many able investigators and with such meager results that many
scientists no longer believe it likely that tobacco smoke exerts any significant effect as a
direct or specific carcinogen for human tissues" [84]. In 1962, Lancet summarized the
results ofthe chemical analysis oftobacco products by noting "no carcinogen has been
found in adequate concentration in tobacco smoke; no genuine lung cancers have been
produced experimentally" [85]. This observation engendered "a slight nagging uncer-
tainty about the evidence ... we must have our carcinogen and our experimental
verification." These requirements can be recognized as a rephrasing of part of the
Henle-Koch postulates so as to apply them to a chronic disease.
In this climate of opinion, it was possible to accept the idea that the epidemiologic
evidence against tobacco was, in general, correct but that the magnitude of the effect
had been overestimated, owing to various uncertainties in the data. If this were the
case, it might be possible to modify tobacco slightly by removing some injurious
constituents without altering to a great extent either its composition or its appeal. In
1961, the Tobacco Research Council, which was funded by cigarette manufacturers,
set up its own laboratories to pinpoint any specific chemicals suspected of being
carcinogens and to"provide a basis forformulating lesscarcinogenicsmoking materials"
[86]. The goal was to produce a safer cigarette, but no progress was made on which
constituents should be removed from tobacco. Berkson's request for research on the
active principle was appropriate, but there was no early explanation of how tobacco
produced lung cancer, the evidence for which many found compelling. There may in
fact be no single active principle in this case; many diseases depend on the interaction
of two or more risk factors, and in 1955 Woodhouse and Hamer suggested that
cigarette smoke might be a co-carcinogen [87].
A further argument used by Berkson is ofgeneral interest even though it was rapidly
countered by ongoing data. He noted that the death rate among the subjects enrolled in
the cohort studies, according to the early publications, was low in relation to general
population death rates, and he drew the inference that the sampling used was so biased
that conclusions based on it would be unreliable [88]. An inference made from an
ongoing study in the early stages, however, becomes a prediction for later findings, and
the low mortality that Berkson observed initially did not last. The death rate subse-
quently rose among smokers and non-smokers, but the differential between these two
groups was consistently maintained. Actuaries are familiar with a phenomenon known
as the wearing off of the effects of medical selection in which some applicants for
insurance are required to pay penalty rates initially, but the survivors ofthe group are
no longer penalized after three or four years. What wore off in the cohort studies was
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the advantage ofabove-average health rather than the handicap of morbidity, but the
mechanism was presumably similar in the two cases.
CRITICISMS BY R.A. FISHER
R.A. Fisher's work on smoking and lung cancer preceded Berkson's and differed in
its thrust; it was published as a booklet in 1959 [89]. In studying the data on smoking,
Fisher [90] emphasized a finding from the Doll-Hill case-control investigation on the
effect of inhalation of the smoke. The proportion of smokers who stated that they
inhaled was 65 percent among the cases and, surprisingly, higher, 67 percent among
the controls. The editorial accompanying the paper in the British Medical Journal in
1950 had commented on this unexpected result [91]. Cornfield and his colleagues
stated in 1959: "It must be admitted that there is no clear explanation of the
contradiction posed"[92]. Fisherpursued the matter to the point ofobtaining original
data from Doll and Hill andpublishing it in his booklet. Smokers among the cases and
among thecontrols wereclassifiedbywhetherthey inhaled when smoking, and the data
werepresented in five subgroups, according to the amount smoked per day. In four of
the fivegroups, the percentage of inhalers among the controls was higher than among
the cases. These data played animportant part in leading Fisher to doubt that tobacco
was a carcinogen. It has subsequently appeared that light smokers deposit little
particulate matter on the susceptible part of the bronchi unless they inhale. Heavy
smokers, on the other hand, who tend to inhale deeply, deposit less when they inhale
than whenthey do not, since in the former case the smoke moves rapidly to the deeper
portions ofthe lungs [93]. The issue deserved the discussion that Fisher prompted and
may occasion more.
Fisher noted that the original hypothesis about the effect of tobacco became an
hypothesis about the effect ofcigarette tobacco. Originally Doll and Hill had treated
an ounce ofpipe tobacco as roughlyequivalent to 28 cigarettes. Fisher regarded them
ashaving modified theirhypothesis tointerpret thevery study that was designed to test
it. This was, hewrote, "themaking ofan assumption which might be true, and indeed,
might not be true, but which, if true, would help to explain what is otherwise
inexplicable" [94]. The force ofthisobjection depended on its timing, since the issue is
whether theassumption is true or not. As more and more investigators failed to negate
it, it has become an accepted view of a difference between the use of pipe tobacco and
cigarette tobacco.
In 1957, Fisher followed others in arguing that the male-to-female ratio in the
incidentcasesoflungcancer was inconsistent with the male-to-female ratio ofsmokers
[95]. Thefindings werecorrect when basedon the ratios seen in the data available for a
restricted period. Research onlung cancer, however, has to take into account the long
latent period between exposure and disease, so that the proportion of incident cases
today depends on the proportion whose exposure began many years ago, and, if the
proportionexposed is increasing ordecreasing over time, the ratio ofcases to exposed,
based on current data, is misleading. There are many examples of a long interval
between an initial exposure and the final disease, including several classic cases in
infectious disease epidemiology. The association of smoking and lung cancer is not
uniqueeither in thelength ofthe latentperiod or in the resulting difficulties in the study
ofthe etiology.
Fisher initially conceded that a good prima facie case had been made out against
smoking [96] but hissummarizingcomplaint was that the attitude toward research on
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lung cancer in the fifties had been marked by "excessive confidence that the solution
has already been found" [97], and he called for continued research, particularly ofthe
type that did not simply repeat designs that had already been exploited repetitively. He
cited the association between blood group A, an inherited factor, and cancer of the
stomach, and proposed two new research projects based on the theory, commonly
known as the constitutional theory, that "cigarette smoking and lung cancer ... are
both influenced by a common cause ... the individual genotype" [98]. He was almost
alone among the major critics in advancing, and indeed pursuing, a proposal for
gathering further empirical data.
The first project was a population survey in which differences in genotype as assessed
by taste testing, secretor status, and blood grouping, would be related to smoking habit.
A simple version of such a study had been completed by Fisher and Vaughan in 1939.
Working in an English town, close to Wales, they had identified Welsh migrants by
their surname, and shown by ABO blood grouping that the persons so identified
differed in genotype from the English majority [99]. If genotype differences were
associated with the subdivision into smoking classes, this finding would at least
encourage further work on the constitutional hypothesis. The proposal for a population
survey of genotypes does not seem to have been taken up, though other differences
between smokers and non-smokers were studied in detail.
Fisher's second proposal called for research on twins and was designed to show
whether there was greater concordance in smoking habit between the members of
monozygotic pairs than there was between members ofdizygotic pairs. Some evidence
that the monozygotes were more concordant was obtained during Fisher's lifetime, and
was based in part on twins who had been reared in different households [100]. The
numbers involved were too small to yield useful information on morbidity or mortality
ofthe twins. Fisher's death occurred in 1962 before the controversy about the effects of
smoking had abated, indeed before the controversy among the general public had
reached a peak. Unlike Berkson, he did not publish a statement concerning the cohort
studies.
The constitutional hypothesis was strongly supported by Brownlee in 1965 in an
unfavorable review of the Surgeon General's Report on Smoking and Health [101].
Writing about the hypothesis some years after it had been introduced, Mantel stated
that it had been difficult to reject [102]. A modified form ofthe hypothesis in which the
interaction between genotype and tobacco is treated as a risk factor remains credible.
The constitutional hypothesis was incompatible, however, in its original form, with the
speed with which lung cancer had increased during this century; Burch, who has
continued to support the constitutional theory, denied that a substantial increase in
lung cancer had, in fact occurred [103]. Since the genotype postulated by the
constitutional theory has not been identified by a phenotypicexpression, any epidemio-
logic research on it has had to be carried out without knowing who had the hypothe-
sized genotype and who did not.
BEGINNING LITERATURE ON METHODOLOGY OF CHRONIC
DISEASE EPIDEMIOLOGY
The cohort and case-control studies ofsmoking, and the controversy they generated,
were of prime interest to those concerned with lung cancer. They also had a wider
influence since they directed attention to methods ofconducting epidemiologic studies
of the etiology of chronic disease. In the course of a few years around the end of the
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fifties, Lilienfeld [104], Sartwell [105], and ajoint team consisting ofYerushalmy and
Palmer [106] wrote about methodology for the new discipline. Lilienfeld, Sartwell, and
Palmer had contributed to research on infectious disease epidemiology, and they used
Koch's postulates, modified by their experience with chronic diseases, to provide a
framework for the new methods; as Yerushalmy and Palmer expressed it in 1959: "It is
the purpose of this paper to develop an elementary parallel between investigation of
etiological factors in certain chronic diseases and those of bacterial diseases."
Yerushalmy and Palmer were ambivalent about the role of smoking in lung cancer.
Their ambivalencedid not sit well with somecolleagues towhom theyshowed a draft of
their paper and, in a footnote responding to the "comments by several very competent
persons" they noted that their statements on smoking and lung cancer were made only
to illustrate methodology and not to express a judgment on the relative value of such
other evidence as might bear on the question.
While the appropriate methods for the study of chronic disease epidemiology were
being discussed, improvements in these methods were being developed. Three publica-
tions in the fifties were especially important in relation to lung cancer and to chronic
disease epidemiology in general.
In 1951, Cornfield showed that the estimates from case-control studies were much
more informative than had been previously supposed [107]. In the caseofsmoking and
lung cancer, for example, the obvious estimates are the proportions ofsmokers among
the cases and also among the controls. These may readily be converted, however, to an
estimate which is more illuminating, namely the risk of lung cancer among smokers
relative to the risk among non-smokers. The higher this relative risk, the less likely is it
that an apparent effect ofsmoking can be explained as an artifact due to confounding.
This likelihood was the basis of one of the arguments used by Cornfield in criticizing
Berkson's dependence on risk differences, rather than risk ratios, injudging the effect
of smoking on the etiology of lung cancer. Cairns was responding to the same logic as
Cornfield when he later wrote that cancer of the lung was so strongly dependent on
smoking that the causal connection could be identified without the need to understand
the underlying mechanism ofcarcinogenesis [108].
A second publication, issued in 1959, was a thorough exposition of the evidence
regarding smoking as a cause of lung cancer. It included an appendix, which is
probably due to Cornfield [109], in which new methodological issues were presented.
An exampleofthese was a quantitative treatment ofan aspectofconfounding. Suppose
smokers and non-smokers arecompared in regard to the occurrenceoflungcancer, and
it is found that the risk among thosewhosmoke, relative totheriskamong thosewhodo
not smoke, is r. Then if cigarette smoking as such is without influence on the
development of lung cancer, and its apparent effect is simply due to confounding, say
by a genotype which is more common in smokers than in non-smokers, the proportion
of smokers with this genotype must be at least r times as great as the proportion of
non-smokers with the genotype. This circumstance puts limits on the extent to which
speculative suggestions can be offered without supporting evidence as a reason for
rejecting a data-based finding in an epidemiologic study ofetiology.
A third influential paper was written by Mantel and Haenszel, who in 1958 provided
a systematic account of the design and analysis of case-control studies [1101. They
gave an exact method ofcombining the evidenceobtained from several strata about the
presence of an association between a risk factor and a disease, and they introduced an
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overall estimate ofthe ratio ofthe odds in favor ofexposure among cases relative to the
corresponding odds among controls.
The methods that flowed from the work on smoking soon became common in chronic
disease epidemiology which, as Vandenbroucke has written, was "heavily rooted in the
smoking-lung cancer controversy" [111]. By the mid-fifties, the major epidemiologic
research that had been published on the etiology of a chronic disease was the research
on smoking. It not only provided an account ofhow such epidemiologic studiescould be
conducted and analyzed, but it also exhibited successful examples.
EFFECT OF EPIDEMIOLOGIC STUDIES OF LUNG CANCER
Innovative work by epidemiologic methods on smoking and lung cancer subsided in
the seventies; the topic, at the epidemiologic level, was becoming exhausted. Lancet
stated in an editorial: "In the fifties the medical profession was equivocal in its attitude
to smoking; in 1970 the profession is more or less united in the view that cigarette
smoking, in particular, endangers health" [112].
In 1970, scientists were not ready to do what Berkson and others had proposed as a
further test ofthe smoking hypothesis: namely, to identify the mechanism that leads to
lung cancer. An editorial in Naturein 1984stated: "It will be timeenough totalkabout
causes of lung cancer, when mechanisms have been worked out... [It] will require
more molecular biology and cell biology ... better understanding of the process of
differentiation and physiology of homeostasis.... People who smoke cigarettes are
more likely than others to develop cancer. The habit ofsmoking is thus ... a cause of
cancer ... [but] not a first cause ... that distinction no doubt lies with a group of
chemicals not yet conclusively demonstrated" [113].
The first cause, thevery first cause,oflung cancer is elusive and thesearch for it may
be never-ending. At any given time, there is also the issue of whether knowledge
obtained by that time can be usefully applied. The epidemiologic evidence agianst
smoking hasjustified a preventivecampaign which has had success in spiteofthe heavy
odds against it. The success is modest in relative terms but beneficial to many people.
The findings laid the basis for a method of avoiding the most common form of lung
cancer and, by adding tobacco to the list of controllable risk factors, they expanded
preventiveoncology far beyond its established roleinreducingoccupationalcarcinogen-
esis and skin cancer.
During the period covered by this study, two of the events that shaped the way in
which chronic disease epidemiologyemerged as a discipline were thedramaticincrease
in lung cancer and the opposition to theclaim thatcigarettesmoking was a major cause
ofthe disease.
The increase in lung cancer, unexpected and, in the short term, unexplained, created
the need for etiologic research. In response to this need the case-control study was
raised to a new level ofquality by Doll and Hill. Themethod is well adapted toetiologic
studies whenever the risk factor can be assessed by taking a subject's history, and it is
especiallyeffective, relative toother methods, when thedisease has a long latent period,
as is typical ofchronic diseases.
The findings from the case-control studies were too important, too unpalatable, and
too surprising to be accepted without extensive criticism, and the reaction to this
criticism had a marked effect on epidemiology. One response was todesign an etiologic
cohort investigation, which demonstrated that a behavioral risk factor could be studied
successfully in a prospective manner. Another was to stimulate interest in improving
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the statistical methods by which epidemiologists analyzed data on the etiology of
chronic disease. Work on an important problem, pursued over many years in the faceof
informed opposition, is likely to lead to methodological advances, and this conse-
quence has been true of research on smoking. Some of these advances came from the
pioneer investigators and some from those who were stimulated by a worthwhile
problem. In the long run, these contributions to methodology may rank in significance
with the substantive findings from the investigation.
Bringing the chronic diseases within the scope of epidemiology has stimulated two
changes in that discipline. The first is the widening ofthe search for etiologic agents in
diseases which had previously been thought of, in large part, as due to degenerative
changes. The principal, though not the sole, agent in the case of infectious diseases is
the organism which acts as the risk factor, and the investigation of the characteristics
and transmission of this agent imparts a special focus to the relevant research. The
organism is a necessary factor in causation of the disease even if it is not a sufficient
factor. In chronic disease the etiologic agent may be an infection, but the disease may
also be due to such factors as diet, behavioral characteristics, occupation, family life,
environmental pollution, inherited abnormality, therapeutic misadventure, or several
factors combined.
A second change which is a consequence of the first is the need for emphasis on
certain knowledge and skills used in research on chronic disease epidemiology. This
development has led to a specialized literature.
Two publications by Doll and Hill, one by Hammond and Horn, and one by Wynder
and Graham [114] played a major part in the early fifties in arousing public and
professional interest in the relation ofsmoking to lung cancer. In all four instances the
papers were published in general medical journals. These very papers, however, were
influential in fostering a discipline ofchronic disease epidemiology which required new
journals or at least modifications of old ones. The British Journal ofPreventive and
Social Medicine and the Journal ofChronic Diseases began publication in 1946 and
1947, respectively, but, although they each published epidemiologic papers, that was
not their sole or even primary function.
In 1965 the American Journal of Hygiene, which had long been an important
journal for the publication of papers on the epidemiology of infectious diseases,
signalled a change of emphasis by altering its name to the American Journal of
Epidemiology. It maintained its interest in infectious diseases but it also rapidly
became an important medium for the publication of papers on chronic disease
epidemiology. This same shift ofemphasis occurred in other countries, and in 1972 the
International Journal ofEpidemiology began publication with similar objectives.
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